Cgp Safety Questions, Cgp Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about Cgp side effects. Our extensive database of Cgp adverse events and Cgp warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Doctors about Cgp
Cgp Safety Reports
Total Cgp reports: 13.Cgp FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 12.
Take Cgp Side Effects Survey or Share Your Cgp Story.
Reported Cgp Side Effects: mucosal inflammation, cardiac pacemaker insertion, atrioventricular block second degree, surgery, sensory disturbance, condition aggravated, benign prostatic hyperplasia, vomiting, c-reactive protein increased, bronchopulmonary aspergillosis, bacteria stool identified.
Read More Here.
Physician from FRANCE reported CGP problem on May 24, 2007. Female patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: asthenia, vomiting. CGP dosage: 400 MG, BID. During the same period patient was treated with METHOTREXATE, CYTARABINE, PREDNISOLONE, DEXAMETHASONE, ZOFRAN, VINCRISTINE. Patient was hospitalized. Patient recovered.
CGP problem was reported by a Physician from UNITED KINGDOM on May 29, 2007. Female patient, 13 years of age, weighting 128.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: bacteraemia, catheter sepsis, hypomagnesaemia, neutropenic sepsis. CGP dosage: 300 MG/M2, QD. Patient was hospitalized. Patient recovered.
Physician from AUSTRALIA reported CGP problem on May 31, 2007. Male patient, 58 years of age, was diagnosed with chordoma and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: dehydration, escherichia urinary tract infection, nausea, oral intake reduced, renal impairment, vomiting. CGP dosage: 600 MG, QD. Patient was hospitalized. Patient recovered.
CGP problem was reported by a Physician from JAPAN on Aug 07, 2006. Male patient, 73 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, condition aggravated, sensory disturbance, surgery. CGP dosage: 400 MG, QD. During the same period patient was treated with PARIET, HALCION, HARNAL, EUGLUCON, HERBESSOR R, ISOSORBIDE MONONITRATE, EXCELASE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported CGP problem on Aug 07, 2006. Male patient, 73 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, condition aggravated, sensory disturbance, surgery. CGP dosage: 400 MG, QD. During the same period patient was treated with PARIET, HALCION, HARNAL, EUGLUCON, HERBESSOR R, ISOSORBIDE MONONITRATE, EXCELASE. Patient was hospitalized. Patient recovered.
CGP problem was reported by a Physician from JAPAN on Aug 30, 2006. Male patient, 79 years of age, was diagnosed with hypertension, angina pectoris, hyperuricaemia, hypercholesterolaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: angina pectoris, coronary artery stenosis, electrocardiogram st segment depression, stent placement. CGP dosage: 80 MG, QD. During the same period patient was treated with ALLOPURINOL, SIGMART, LIPITOR. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CGP problem on Oct 13, 2006. Male patient, 21 years of age, weighting 152.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, blood bilirubin abnormal, hepatomegaly, hepatotoxicity, leukaemic infiltration hepatic, mucosal inflammation. CGP dosage: 400 MG, BID. Patient recovered.
CGP problem was reported by a Physician from JAPAN on July 07, 2005. Male patient, 74 years of age, weighting 149.9 lb, was diagnosed with chronic myeloid leukaemia, angina pectoris, hypertension, prophylaxis against gastrointestinal ulcer, orthostatic hypotension, hyperuricaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: endoscopy upper gastrointestinal tract, gastric antral vascular ectasia, gastric haemorrhage, gastric mucosal lesion, iron deficiency anaemia. CGP dosage: 400 MG, QD. During the same period patient was treated with ASPIRIN, BLOPRESS, SIGMART, MUCOSTA, RISUMIC, HERBESSOR R, SALOBEL. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CGP problem on Dec 01, 2006. Female patient, 26 years of age, weighting 94.80 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: abdominal pain, aplasia, central line infection, central venous catheterisation, constipation, fungal infection, ileus, mouth ulceration, mucosal inflammation. CGP dosage: 800 MG, QD. During the same period patient was treated with MORPHINE. Patient was hospitalized. Patient recovered.
CGP problem was reported by a Physician from FRANCE on Dec 04, 2006. Female patient, 40 years of age, weighting 105.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, mucosal inflammation, oesophagitis, pancytopenia, pharyngitis. CGP dosage: 400 MG, QD. During the same period patient was treated with PURINETHOL, METHOTREXATE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CGP problem on Dec 15, 2006. Female patient, 71 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, cardiac pacemaker insertion. CGP dosage: 300 MG, QD. Patient was hospitalized. Patient recovered.
CGP problem was reported by a Physician from FRANCE on Dec 15, 2006. Female patient, 71 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: atrioventricular block second degree, cardiac pacemaker insertion. CGP dosage: 300 MG, QD. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported CGP problem on Sept 05, 2007. Male patient, 49 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased. CGP dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.